NAVLE Endocrine

Canine Diabetic Ketoacidosis Study Guide

📅 March 28, 2026 ⏱ 25 min read

Diabetic ketoacidosis (DKA) is a life-threatening complication of diabetes mellitus characterized by the biochemical triad of hyperglycemia, ketonemia (or ketonuria), and metabolic acidosis.

Overview and Clinical Importance

Diabetic ketoacidosis (DKA) is a life-threatening complication of diabetes mellitus characterized by the biochemical triad of hyperglycemia, ketonemia (or ketonuria), and metabolic acidosis. It represents one of the most common endocrine emergencies in veterinary medicine and requires intensive hospitalization with aggressive fluid therapy and insulin administration. DKA occurs when absolute or relative insulin deficiency prevents glucose from entering cells, forcing the body to rely on fat metabolism for energy, which produces acidic ketone bodies.

Approximately 65-70% of dogs with DKA are newly diagnosed diabetics at the time of presentation. Concurrent diseases are present in over 70% of cases, with the most common being acute pancreatitis (40-41%), urinary tract infections (20%), and hyperadrenocorticism (15%). The presence of hyperadrenocorticism is associated with significantly worse outcomes.

Ketone Body	Characteristics	Detection
Beta-hydroxybutyrate (BHB)	Most abundant in DKA; technically a hydroxy acid, not a true ketone	Point-of-care ketone meters (most sensitive); NOT detected by urine dipstick
Acetoacetate	Only true ketoacid chemically; converts to BHB in presence of NADH	Detected by urine dipstick (nitroprusside reaction)
Acetone	True ketone; volatile; causes fruity breath odor	Clinical detection (breath); partially by urine dipstick

Pathophysiology

Insulin Deficiency and Counter-Regulatory Hormones

DKA develops from an absolute or relative insulin deficiency combined with elevated counter-regulatory hormones (glucagon, cortisol, catecholamines, and growth hormone). In dogs, Type 1 diabetes mellitus (absolute insulin deficiency due to beta-cell destruction) is the most common form. The pathogenesis involves genetic predisposition, autoimmune mechanisms, and environmental factors.

Key metabolic derangements:

Hyperglycemia: Results from increased gluconeogenesis, glycogenolysis, and decreased glucose utilization by peripheral tissues
Lipolysis: Hormone-sensitive lipase breaks down triglycerides into free fatty acids (FFAs) due to lack of insulin inhibition
Ketogenesis: FFAs undergo beta-oxidation in hepatocytes to form acetyl-CoA, which is converted to ketone bodies (beta-hydroxybutyrate, acetoacetate, acetone)
Metabolic acidosis: Ketone bodies are strong acids that overwhelm buffering capacity, causing high anion gap metabolic acidosis

High-YieldThe DKA acronym itself reminds you of the diagnostic triad: D = Diabetes/hyperglycemia (glucose greater than 250 mg/dL), K = Ketonemia/ketonuria, A = Acidosis (pH less than 7.3, bicarbonate less than 15 mEq/L). All three must be present for a diagnosis of DKA.

Ketone Body Formation and Detection

Three ketone bodies are produced during DKA:

NAVLE TipUrine dipsticks can give FALSE NEGATIVE results in DKA because they only detect acetoacetate, not beta-hydroxybutyrate (the predominant ketone). As acidosis is corrected with treatment, paradoxically the urine ketones may appear to INCREASE because BHB converts back to the measurable acetoacetate. Point-of-care blood ketone meters measuring BHB (cutoff greater than 3.8 mmol/L in dogs) are more accurate for diagnosis and monitoring.

Signs of Diabetes Mellitus	Signs of DKA Crisis
Polyuria and polydipsia Polyphagia Weight loss Diabetic cataracts Hepatomegaly	Anorexia and vomiting Lethargy and depression Dehydration (5-12%) Kussmaul breathing (deep, rapid) Fruity (acetone) breath Weakness and collapse Hypothermia Obtundation or coma

Clinical Presentation

Signalment and Predisposition

Age: Most commonly affects middle-aged to older dogs (greater than 7 years)

Sex: Female dogs, particularly intact females, are more prone to DKA. Diestrus and pregnancy can trigger diabetes mellitus due to progesterone-induced insulin resistance.

Breed predisposition: Breeds predisposed to diabetes mellitus are also predisposed to DKA, including Miniature and Toy Poodles, Miniature Schnauzers, Beagles, Cairn Terriers, Samoyeds, and Australian Terriers.

Clinical Signs

Clinical signs range from mild dehydration to complete cardiovascular collapse. Signs may be attributed to chronic untreated diabetes, concurrent diseases, or the acute metabolic crisis.

Parameter	DKA Criteria	Clinical Notes
Blood Glucose	Greater than 250 mg/dL	Often greater than 500 mg/dL; Renal threshold: 180-200 mg/dL
Ketones	BHB greater than 3.8 mmol/L	Blood BHB measurement preferred over urine
Venous pH	Less than 7.3	Mild: 7.2-7.3; Moderate: 7.1-7.2; Severe: less than 7.1
Bicarbonate	Less than 15 mEq/L	Correlates with severity of acidosis
Anion Gap	Greater than 24 mEq/L	Normal: 12-24 mEq/L

Diagnosis

Diagnostic Criteria

The diagnosis of DKA requires documentation of the biochemical triad:

Electrolyte Abnormalities

High-YieldTotal body potassium is ALWAYS depleted in DKA, even when serum K+ appears normal or high. Acidosis causes H+ to move into cells in exchange for K+ moving out, masking the true deficit. Once insulin is started, K+ rapidly shifts back into cells, unmasking severe hypokalemia. ALWAYS delay insulin until K+ is at least 3.3-3.5 mEq/L and supplement aggressively!

Electrolyte	Finding	Mechanism
Sodium	Often low (pseudohyponatremia)	Dilutional from osmotic water shift
Potassium	Variable (30-43% low at presentation)	Total body K+ depleted; acidosis shifts K+ out of cells
Phosphorus	Variable; drops with treatment	Osmotic diuresis; shifts intracellularly with insulin

Concurrent Diseases

Over 70% of dogs with DKA have concurrent diseases that either precipitate DKA or complicate treatment.

NAVLE TipThe three most common concurrent conditions in canine DKA are the "3 P's": Pancreatitis, Pee infections (UTI), and Pituitary-dependent hyperadrenocorticism (Cushing's). Of these, Cushing's disease carries the WORST prognosis for DKA.

Condition	Prevalence	Clinical Significance
Acute Pancreatitis	40-41%	Most common; may prolong hospitalization; cPLI testing recommended
UTI	20%	Glucosuria provides bacterial substrate; always culture urine
Hyperadrenocorticism	15%	Associated with WORSE prognosis; causes insulin resistance

Treatment

Treatment of DKA requires intensive hospitalization (typically 5-6 days). The four pillars are: fluid therapy, electrolyte replacement, insulin administration, and treatment of concurrent diseases.

Fluid Therapy

Fluid therapy is the MOST IMPORTANT initial treatment and should begin immediately, even before insulin.

Potassium Supplementation Protocol

Exam Focus: Maximum potassium infusion rate should NOT exceed 0.5 mEq/kg/hr. If K+ less than 3.0-3.5 mEq/L, DELAY insulin and supplement potassium first!

Insulin Therapy

Regular insulin (short-acting) is standard. Start insulin within 6 hours but ONLY after fluid resuscitation and K+ at least 3.5 mEq/L.

High-YieldBlood glucose should NOT decrease faster than 50-100 mg/dL/hr. Continue insulin even when glucose normalizes - the goal is to resolve KETOSIS, not just hyperglycemia. Add dextrose to fluids when glucose less than 250 mg/dL.

Parameter	Recommendation
Fluid Type	0.9% NaCl traditional; balanced crystalloids (LRS) also acceptable
Shock Resuscitation	10-20 mL/kg boluses over 15-20 minutes; reassess and repeat
Rehydration	Replace deficit over 12-24 hours: % dehydration x BW (kg) x 1000
Dextrose Addition	Add 2.5-5% when glucose drops below 250 mg/dL

Prognosis

Survival rate: Approximately 70% with aggressive treatment. Median hospitalization: 6 days.

Negative Prognostic Indicators

Concurrent hyperadrenocorticism (significantly worse outcomes)
Lower ionized calcium; lower hematocrit
More severe acidosis (lower pH, larger base deficit)

Serum K+ (mEq/L)	KCl to Add (mEq/L)	Max Rate
Greater than 3.5	20	0.5 mEq/kg/hr
3.0-3.5	40	0.5 mEq/kg/hr
2.5-3.0	60	0.5 mEq/kg/hr
Less than 2.5	80-120	0.5 mEq/kg/hr with ECG

Protocol	Dosing	Notes
IV CRI (Preferred)	2.2 U/kg in 250 mL NaCl at 10 mL/hr	Delivers approximately 0.09 U/kg/hr; use separate IV line
Intermittent IM	Initial 0.2 U/kg IM, then 0.1 U/kg IM hourly	Alternative when CRI not possible

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →